A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease
J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, C McCabe, C Meads
Research output: Contribution to journal › Article › peer-review
88Citations
(Scopus)
Fingerprint
Dive into the research topics of 'A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease'. Together they form a unique fingerprint.